Management of cushing's disease after failed surgery-a review

Canadian Journal of Neurological Sciences

Volumn 38, Issue 1, 2011, Pages 12-21

  McLaughlin, Nancy ^a   Kassam, Amin B ^a   Prevedello, Daniel M ^a   Kelly, Daniel F ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; GLUCOCORTICOID; HYDROCORTISONE; KETOCONAZOLE; MIFEPRISTONE; OCTREOTIDE; PASIREOTIDE; TEMOZOLOMIDE;

ADRENALECTOMY; CANCER GROWTH; CAVERNOUS SINUS; CORTICOTROPIN BLOOD LEVEL; CUSHING DISEASE; DISEASE ASSOCIATION; FOLLOW UP; GAMMA KNIFE RADIOSURGERY; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; HYPERCORTISOLISM; HYPERPIGMENTATION; HYPOPITUITARISM; INFERIOR PETROSAL SINUS; LIQUORRHEA; MICROADENOMA; NELSON SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROVOCATION TEST; RECURRENT DISEASE; RELAPSE; REMISSION; REOPERATION; REVIEW; TRANSSPHENOIDAL SURGERY; TREATMENT FAILURE; HYPOPHYSECTOMY; METHODOLOGY; POSTOPERATIVE COMPLICATION; TREATMENT OUTCOME;

ADRENALECTOMY; HUMANS; HYPOPHYSECTOMY; PITUITARY ACTH HYPERSECRETION; POSTOPERATIVE COMPLICATIONS; RECURRENCE; REOPERATION; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 79952276670     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/s031716710012075x     Document Type: Review

References (105)

1. Bertagna X, Guignat L, Groussin L, Bertherat J. Cushing's disease. Best Pract Res Clin Endocrinol Metab. 2009 Oct;23(5):607-23.
2. Hammer GD, Tyrrell JB, Lamborn KR, et al. Transsphenoidal microsurgery for Cushing's disease: initial outcome and longterm results. J Clin Endocrinol Metab. 2004 Dec;89(12): 6348-57. (Pubitemid 39628458)
3. Lindholm J, Juul S, Jorgensen JO, et al. Incidence and late prognosis of cushing's syndrome: a population-based study. J Clin Endocrinol Metab. 2001 Jan;86(1):117-23. (Pubitemid 32111743)
4. Atkinson AB, Kennedy A, Wiggam MI, McCance DR, Sheridan B. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance. Clin Endocrinol (Oxf). 2005 Nov;63(5):549-59. (Pubitemid 41626751)
5. Mancini T, Kola B, Mantero F, Boscaro M, Arnaldi G. High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines. Clin Endocrinol (Oxf). 2004 Dec;61(6):768-77. (Pubitemid 40006799)
6. Ross EJ, Linch DC. The clinical response to treatment in adult Cushing's syndrome following remission of hypercortisolaemia. Postgrad Med J. 1985 Mar;61(713):205-11. (Pubitemid 15108059)
7. Kelly DF. Transsphenoidal surgery for Cushing's disease: a review of success rates, remission predictors, management of failed surgery, and Nelson's Syndrome. Neurosurg Focus. 2007;23 (3):E5.
8. Liu JK, Fleseriu M, Delashaw JB, Jr., Ciric IS, Couldwell WT. Treatment options for Cushing disease after unsuccessful transsphenoidal surgery. Neurosurg Focus. 2007;23(3):E8.
9. Dehdashti AR, Gentili F. Current state of the art in the diagnosis and surgical treatment of Cushing disease: early experience with a purely endoscopic endonasal technique. Neurosurg Focus. 2007; 23(3):E9.
10. Esposito F, Dusick JR, Cohan P, et al. Clinical review: early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing's disease. J Clin Endocrinol Metab. 2006 Jan;91(1):7-13. (Pubitemid 43069107)
11. Hofmann BM, Hlavac M, Martinez R, Buchfelder M, Muller OA, Fahlbusch R. Long-term results after microsurgery for Cushing disease: experience with 426 primary operations over 35 years. J Neurosurg. 2008 Jan;108(1):9-18.
12. Fomekong E, Maiter D, Grandin C, Raftopoulos C. Outcome of transsphenoidal surgery for Cushing's disease: a high remission rate in ACTH-secreting macroadenomas. Clin Neurol Neurosurg. 2009 Jun;111(5):442-9.
13. Shimon I, Ram Z, Cohen ZR, Hadani M. Transsphenoidal surgery for Cushing's disease: endocrinological follow-up monitoring of 82 patients. Neurosurgery. 2002 Jul;51(1):57-61; discussion-2.
14. Wagenmakers MA, Netea-Maier RT, van Lindert EJ, Timmers HJ, Grotenhuis JA, Hermus AR. Repeated transsphenoidal pituitary surgery (TS) via the endoscopic technique: a good therapeutic option for recurrent or persistent Cushing's disease (CD). Clin Endocrinol (Oxf). 2009 Feb;70(2):274-80.
15. Beauregard C, Dickstein G, Lacroix A. Classic and recent etiologies of Cushing's syndrome: diagnosis and therapy. Treat Endocrinol. 2002;1(2):79-94. (Pubitemid 36828428)
16. Aghi MK. Management of recurrent and refractory Cushing disease. Nat Clin Pract Endocrinol Metab. 2008 Oct;4(10): 560-8.
17. Barbetta L, Dall'Asta C, Tomei G, Locatelli M, Giovanelli M, Ambrosi B. Assessment of cure and recurrence after pituitary surgery for Cushing's disease. Acta Neurochir (Wien). 2001;143 (5):477-81; discussion 81-2.
18. Aghi MK, Petit J, Chapman P, et al. Management of recurrent and refractory Cushing's disease with reoperation and/or proton beam radiosurgery. Clin Neurosurg. 2008;55:141-4.
19. Bochicchio D, Losa M, Buchfelder M. Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group. J Clin Endocrinol Metab. 1995 Nov;80(11):3114-20.
20. Hofmann BM, Fahlbusch R. Treatment of Cushing's disease: a retrospective clinical study of the latest 100 cases. Front Horm Res. 2006;34:158-84. (Pubitemid 43265658)
21. Rollin GA, Ferreira NP, Junges M, Gross JL, Czepielewski MA. Dynamics of serum cortisol levels after transsphenoidal surgery in a cohort of patients with Cushing's disease. J Clin Endocrinol Metab. 2004 Mar;89(3):1131-9. (Pubitemid 38368401)
22. Simmons NE, Alden TD, Thorner MO, Laws ER, Jr. Serum cortisol response to transsphenoidal surgery for Cushing disease. J Neurosurg. 2001 Jul;95(1):1-8. (Pubitemid 32799766)
23. Yap LB, Turner HE, Adams CB, Wass JA. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit. Clin Endocrinol (Oxf). 2002 Jan;56(1):25-31. (Pubitemid 34107318)
24. McCance DR, Besser M, Atkinson AB. Assessment of cure after transsphenoidal surgery for Cushing's disease. Clin Endocrinol (Oxf). 1996 Jan;44(1):1-6. (Pubitemid 26025679)
25. Trainer PJ, Lawrie HS, Verhelst J, et al. Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successful treatment. Clin Endocrinol (Oxf). 1993 Jan;38(1):73-8. (Pubitemid 23030276)
26. Burke CW, Adams CB, Esiri MM, Morris C, Bevan JS. Transsphenoidal surgery for Cushing's disease: does what is removed determine the endocrine outcome? Clin Endocrinol (Oxf). 1990 Oct;33(4):525-37. (Pubitemid 20290692)
27. Blevins LS, Jr., Sanai N, Kunwar S, Devin JK. An approach to the management of patients with residual Cushing's disease. J Neurooncol. 2009 Sep;94(3):313-9.
28. Dickerman RD, Oldfield EH. Basis of persistent and recurrent Cushing disease: an analysis of findings at repeated pituitary surgery. J Neurosurg. 2002 Dec;97(6):1343-9. (Pubitemid 35424289)
29. De Tommasi C, Vance ML, Okonkwo DO, Diallo A, Laws ER, Jr. Surgical management of adrenocorticotropic hormone-secreting macroadenomas: outcome and challenges in patients with Cushing's disease or Nelson's syndrome. J Neurosurg. 2005 Nov; 103(5):825-30. (Pubitemid 43194575)
30. Meij B, Voorhout G, Rijnberk A. Progress in transsphenoidal hypophysectomy for treatment of pituitary-dependent hyperadrenocorticism in dogs and cats. Mol Cell Endocrinol. 2002 Nov 29;197(1-2):89-96. (Pubitemid 35304783)
31. Swearingen B, Biller BM, Barker FG, 2nd, et al. Long-term mortality after transsphenoidal surgery for Cushing disease. Ann Intern Med. 1999 May 18;130(10):821-4. (Pubitemid 29231150)
32. Scheithauer BW, Gaffey TA, Lloyd RV, et al. Pathobiology of pituitary adenomas and carcinomas. Neurosurgery. 2006 Aug;59 (2):341-53; discussion 53. (Pubitemid 44325877)
33. Hague K, Post KD, Morgello S. Absence of peritumoral Crooke's change is associated with recurrence in surgically treated Cushing's disease. Surg Neurol. 2000 Jan;53(1):77-81. (Pubitemid 30099591)
34. Felix IA, Horvath E, Kovacs K. Massive Crooke's hyalinization in corticotroph cell adenomas of the human pituitary. A histological, immunocytological, and electron microscopic study of three cases. Acta Neurochir (Wien). 1981;58(3-4):235-43. (Pubitemid 12238353)
35. George DH, Scheithauer BW, Kovacs K, et al. Crooke's cell adenoma of the pituitary: an aggressive variant of corticotroph adenoma. Am J Surg Pathol. 2003 Oct;27(10):1330-6. (Pubitemid 37185824)
36. Nakane T, Kuwayama A, Watanabe M, et al. Long term results of transsphenoidal adenomectomy in patients with Cushing's disease. Neurosurgery. 1987 Aug;21(2):218-22. (Pubitemid 17131122)
37. Tindall GT, Herring CJ, Clark RV, Adams DA,Watts NB. Cushing's disease: results of transsphenoidal microsurgery with emphasis on surgical failures. J Neurosurg. 1990 Mar;72(3):363-9. (Pubitemid 20072957)
38. Pereira AM, van Aken MO, van Dulken H, et al. Long-term predictive value of postsurgical cortisol concentrations for cure and risk of recurrence in Cushing's disease. J Clin Endocrinol Metab. 2003 Dec;88(12):5858-64. (Pubitemid 38033063)
39. Knappe UJ, Ludecke DK. Persistent and recurrent hypercortisolism after transsphenoidal surgery for Cushing's disease. Acta Neurochir Suppl. 1996;65:31-4. (Pubitemid 126446155)
40. Hofmann BM, Hlavac M, Kreutzer J, Grabenbauer G, Fahlbusch R. Surgical treatment of recurrent Cushing's disease. Neurosurgery. 2006 Jun;58(6):1108-18; discussion 18.
41. Tabarin A, Laurent F, Catargi B, et al. Comparative evaluation of conventional and dynamic magnetic resonance imaging of the pituitary gland for the diagnosis of Cushing's disease. Clin Endocrinol (Oxf). 1998 Sep;49(3):293-300. (Pubitemid 28448937)
42. Erickson D, Erickson B, Watson R, et al. 3 Tesla magnetic resonance imaging with and without corticotropin releasing hormone stimulation for the detection of microadenomas in Cushing's syndrome. Clin Endocrinol (Oxf). 2010 Jun;72(6): 793-9.
43. Kim LJ, Lekovic GP, White WL, Karis J. Preliminary Experience with 3-Tesla MRI and Cushing's disease. Skull Base. 2007 Jul; 17(4):273-7. (Pubitemid 47408215)
44. Oldfield EH, Doppman JL, Nieman LK, et al. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. N Engl J Med. 1991 Sep 26;325(13):897-905.
45. Locatelli M, Vance ML, Laws ER. Clinical review: the strategy of immediate reoperation for transsphenoidal surgery for Cushing's disease. J Clin Endocrinol Metab. 2005 Sep;90(9):5478-82. (Pubitemid 41262319)
46. Ram Z, Nieman LK, Cutler GB, Jr., Chrousos GP, Doppman JL, Oldfield EH. Early repeat surgery for persistent Cushing's disease. J Neurosurg. 1994 Jan;80(1):37-45. (Pubitemid 24020703)
47. Patil CG, Veeravagu A, Prevedello DM, Katznelson L, Vance ML, Laws ER, Jr. Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease. Neurosurgery. 2008 Aug;63(2):266-70; discussion: 70-1.
48. Fatemi N, Dusick JR, de Paiva Neto MA, Kelly DF. The endonasal microscopic approach for pituitary adenomas and other parasellar tumors: a 10-year experience. Neurosurgery. 2008 Oct;63(4 Suppl 2):244-56; discussion 256.
49. Dusick JR, Esposito F, Malkasian D, Kelly DF. Avoidance of carotid artery injuries in transsphenoidal surgery with the Doppler probe and micro-hook blades. Neurosurgery. 2007 Apr; 60(4 Suppl 2):322-8; discussion 328-9.
50. Jagannathan J, Smith R, DeVroom HL, et al. Outcome of using the histological pseudocapsule as a surgical capsule in Cushing disease. J Neurosurg. 2009 Sep;111(3):531-9.
51. Fatemi N, Dusick JR, Mattozo C, et al. Pituitary hormonal loss and recovery after transsphenoidal adenoma removal. Neurosurgery. 2008 Oct;63(4):709-18; discussion 718-9.
52. Cavallo LM, de Divitiis O, Aydin S, et al. Extended endoscopic endonasal transsphenoidal approach to the suprasellar area: anatomic considerations-part 1. Neurosurgery. 2007 Sep;61(3 Suppl):24-33; discussion 34.
53. Kassam A, Snyderman CH, Mintz A, Gardner P, Carrau RL. Expanded endonasal approach: the rostrocaudal axis. Part I. Crista galli to the sella turcica. Neurosurg Focus. 2005 Jul 15;19 (1):E3.
54. Kassam A, Snyderman CH, Mintz A, Gardner P, Carrau RL. Expanded endonasal approach: the rostrocaudal axis. Part II. Posterior clinoids to the foramen magnum. Neurosurg Focus. 2005 Jul 15;19(1):E4.
55. Kitano M, Taneda M, Shimono T, Nakao Y. Extended transsphenoidal approach for surgical management of pituitary adenomas invading the cavernous sinus. J Neurosurg. 2008 Jan; 108(1):26-36.
56. Hardy J. Presidential address: XVII Canadian Congress of Neurological Sciences. Cushing's disease: 50 years later. Can J Neurol Sci. 1982 Nov;9(4):375-80.
57. Weil RJ, Vortmeyer AO, Nieman LK, Devroom HL, Wanebo J, Oldfield EH. Surgical remission of pituitary adenomas confined to the neurohypophysis in Cushing's disease. J Clin Endocrinol Metab. 2006 Jul;91(7):2656-64. (Pubitemid 44024633)
58. Friedman RB, Oldfield EH, Nieman LK, et al. Repeat transsphenoidal surgery for Cushing's disease. J Neurosurg. 1989 Oct;71(4):520-7. (Pubitemid 19244267)
59. Rudnik A, Zawadzki T, Galuszka-Ignasiak B, et al. Endoscopic transsphenoidal treatment in recurrent and residual pituitary adenomas-first experience. Minim Invasive Neurosurg. 2006 Feb;49(1):10-4.
60. Chee GH, Mathias DB, James RA, Kendall-Taylor P. Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome? Clin Endocrinol (Oxf). 2001 May;54(5): 617-26. (Pubitemid 34208905)
61. Benveniste RJ, King WA, Walsh J, Lee JS, Delman BN, Post KD. Repeated transsphenoidal surgery to treat recurrent or residual pituitary adenoma. J Neurosurg. 2005 Jun;102(6):1004-12. (Pubitemid 43193968)
62. Biller BM, Grossman AB, Stewart PM, et al. Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab. 2008 Jul;93(7):2454-62. (Pubitemid 352008503)
63. Estrada J, Boronat M, Mielgo M, et al. The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease. N Engl J Med. 1997 Jan 16;336(3):172-7. (Pubitemid 27034962)
64. Becker G, Kocher M, Kortmann RD, et al. Radiation therapy in the multimodal treatment approach of pituitary adenoma. Strahlenther Onkol. 2002 Apr;178(4):173-86. (Pubitemid 34309264)
65. Zierhut D, Flentje M, Adolph J, Erdmann J, Raue F,Wannenmacher M. External radiotherapy of pituitary adenomas. Int J Radiat Oncol Biol Phys. 1995 Sep 30;33(2):307-14.
66. Brada M, Ford D, Ashley S, et al. Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma. BMJ. 1992 May 23;304(6838):1343-6.
67. Simmons NE, Laws ER, Jr. Glioma occurrence after sellar irradiation: case report and review. Neurosurgery. 1998 Jan;42 (1):172-8. (Pubitemid 28067041)
68. Salinger DJ, Brady LW, Miyamoto CT. Radiation therapy in the treatment of pituitary adenomas. Am J Clin Oncol. 1992 Dec;15 (6):467-73.
69. Constine LS, Woolf PD, Cann D, et al. Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med. 1993 Jan 14;328(2):87-94.
70. Colin P, Delemer B, Nakib I, et al. [Unsuccessful surgery of Cushing's disease. Role and efficacy of fractionated stereotactic radiotherapy]. Neurochirurgie. 2002 May;48(2-3 Pt 2):285-93. (Pubitemid 34606340)
71. Colin P, Jovenin N, Delemer B, et al. Treatment of pituitary adenomas by fractionated stereotactic radiotherapy: a prospective study of 110 patients. Int J Radiat Oncol Biol Phys. 2005 Jun 1;62(2):333-41. (Pubitemid 40704447)
72. Sheehan JP, Niranjan A, Sheehan JM, et al. Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium. J Neurosurg. 2005 Apr;102(4):678-91. (Pubitemid 43186673)
73. Sheehan JM, Vance ML, Sheehan JP, Ellegala DB, Laws ER, Jr. Radiosurgery for Cushing's disease after failed transsphenoidal surgery. J Neurosurg. 2000 Nov;93(5):738-42. (Pubitemid 32803394)
74. Jagannathan J, Sheehan JP, Pouratian N, Laws ER, Steiner L, Vance ML. Gamma Knife surgery for Cushing's disease. J Neurosurg. 2007 Jun;106(6):980-7. (Pubitemid 46871110)
75. Castinetti F, Nagai M, Dufour H, et al. Gamma knife radiosurgery is a successful adjunctive treatment in Cushing's disease. Eur J Endocrinol. 2007 Jan;156(1):91-8. (Pubitemid 46553907)
76. Oyesiku NM. Stereotactic radiosurgery for Cushing disease: a review. Neurosurg Focus. 2007;23(6):E14.
77. Kobayashi T, Kida Y, Mori Y. Gamma knife radiosurgery in the treatment of Cushing disease: long-term results. J Neurosurg. 2002 Dec;97 Suppl 5:422-8. (Pubitemid 35424317)
78. Petit JH, Biller BM, Yock TI, et al. Proton stereotactic radiotherapy for persistent adrenocorticotropin-producing adenomas. J Clin Endocrinol Metab. 2008 Feb;93(2):393-9. (Pubitemid 351246676)
79. Lyman JT, Phillips MH, Frankel KA, Levy RP, Fabrikant JI. Radiation physics for particle beam radiosurgery. Neurosurg Clin N Am. 1992 Jan;3(1):1-8.
80. Miller JW, Crapo L. The medical treatment of Cushing's syndrome. Endocr Rev. 1993 Aug;14(4):443-58. (Pubitemid 23238926)
81. Fleseriu M, Loriaux DL, Ludlam WH. Second-line treatment for Cushing's disease when initial pituitary surgery is unsuccessful. Curr Opin Endocrinol Diabetes Obes. 2007 Aug;14(4):323-8. (Pubitemid 47067119)
82. O'Riordain DS, Farley DR, Young WF, Jr., Grant CS, van Heerden JA. Long-term outcome of bilateral adrenalectomy in patients with Cushing's syndrome. Surgery. 1994 Dec;116(6):1088-93; discussion 1093-4.
83. Smith PW, Turza KC, Carter CO, Vance ML, Laws ER, Hanks JB. Bilateral adrenalectomy for refractory Cushing disease: a safe and definitive therapy. J Am Coll Surg. 2009 Jun;208(6): 1059-64.
84. Chow JT, Thompson GB, Grant CS, Farley DR, Richards ML, Young WF, Jr. Bilateral laparoscopic adrenalectomy for corticotrophin-dependent Cushing's syndrome: a review of the Mayo Clinic experience. Clin Endocrinol (Oxf). 2008 Apr;68 (4):513-9. (Pubitemid 351388707)
85. Thompson SK, Hayman AV, Ludlam WH, Deveney CW, Loriaux DL, Sheppard BC. Improved quality of life after bilateral laparoscopic adrenalectomy for Cushing's disease: a 10-year experience. Ann Surg. 2007 May;245(5):790-4. (Pubitemid 46684110)
86. Assie G, Bahurel H, Coste J, et al. Corticotroph tumor progression after adrenalectomy in Cushing's Disease: a reappraisal of Nelson's Syndrome. J Clin Endocrinol Metab. 2007 Jan;92(1): 172-9. (Pubitemid 46067527)
87. Pereira MA, Halpern A, Salgado LR, et al. A study of patients with Nelson's syndrome. Clin Endocrinol (Oxf). 1998 Oct;49(4): 533-9. (Pubitemid 28475348)
88. Nagesser SK, van Seters AP, Kievit J, et al. Treatment of pituitarydependent Cushing's syndrome: long-term results of unilateral adrenalectomy followed by external pituitary irradiation compared to transsphenoidal pituitary surgery. Clin Endocrinol (Oxf). 2000 Apr;52(4):427-35. (Pubitemid 30249810)
89. Invitti C, Giraldi FP, de Martin M, Cavagnini F. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. J Clin Endocrinol Metab. 1999 Feb; 84(2):440-8.
90. Favia G, Boscaro M, Lumachi F, D'Amico DF. Role of bilateral adrenalectomy in Cushing's disease. World J Surg. 1994 Jul-Aug;18(4):462-6. (Pubitemid 24273841)
91. Kemink SA, Wesseling P, Pieters GF, Verhofstad AA, Hermus AR, Smals AG. Progression of a Nelson's adenoma to pituitary carcinoma; a case report and review of the literature. J Endocrinol Invest. 1999 Jan;22(1):70-5. (Pubitemid 29095018)
92. Nagesser SK, van Seters AP, Kievit J, Hermans J, Krans HM, van de Velde CJ. Long-term results of total adrenalectomy for Cushing's disease. World J Surg. 2000 Jan;24(1):108-13.
93. Kemink SA, Grotenhuis JA, De Vries J, Pieters GF, Hermus AR, Smals AG. Management of Nelson's syndrome: observations in fifteen patients. Clin Endocrinol (Oxf). 2001 Jan;54(1):45-52. (Pubitemid 32158704)
94. Saeger W. Surgical pathology of the pituitary in Cushing's disease. Pathol Res Pract. 1991 Jun;187(5):613-6.
95. Kelly PA, Samandouras G, Grossman AB, Afshar F, Besser GM, Jenkins PJ. Neurosurgical treatment of Nelson's syndrome. J Clin Endocrinol Metab. 2002 Dec;87(12):5465-9. (Pubitemid 36034345)
96. Wislawski J, Kasperlik-Zaluska AA, Jeske W, et al. Results of neurosurgical treatment by a transsphenoidal approach in 10 patients with Nelson's syndrome. J Neurosurg. 1985 Jan;62(1): 68-71. (Pubitemid 15199405)
97. Xing B, Ren Z, Su C, Wang R, Yang Y, Hu Y. Microsurgical treatment of Nelson's syndrome. Chin Med J (Engl). 2002 Aug; 115(8):1150-2. (Pubitemid 34947331)
98. Ganz JC, Aanderud S, Mork SJ, Smievoll AI. Tumour volume reduction following gamma knife radiosurgery: the relationship between X-ray and histological findings. Acta Neurochir Suppl. 1994;62:39-42.
99. Jenkins PJ, Trainer PJ, Plowman PN, et al. The long-term outcome after adrenalectomy and prophylactic pituitary radiotherapy in adrenocorticotropin- dependent Cushing's syndrome. J Clin Endocrinol Metab. 1995 Jan;80(1):165-71.
100. de Bruin C, Feelders RA, Lamberts SW, Hofland LJ. Somatostatin and dopamine receptors as targets for medical treatment of Cushing's Syndrome. Rev Endocr Metab Disord. 2009 Jun;10 (2):91-102.
101. Batista DL, Zhang X, Gejman R, et al. The effects of SOM230 on cell proliferation and adrenocorticotropin secretion in human corticotroph pituitary adenomas. J Clin Endocrinol Metab. 2006 Nov;91(11):4482-8. (Pubitemid 44833427)
102. Hofland LJ, van der Hoek J, Feelders R, et al. The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5. Eur J Endocrinol. 2005 Apr;152(4):645-54. (Pubitemid 40575811)
103. Moyes VJ, Alusi G, Sabin HI, et al. Treatment of Nelson's syndrome with temozolomide. Eur J Endocrinol. 2009 Jan;160(1):115-9.
104. Ragel BT, Couldwell WT. Pituitary carcinoma: a review of the literature. Neurosurg Focus. 2004 Apr 15;16(4):E7.
105. Landman RE, Horwith M, Peterson RE, Khandji AG, Wardlaw SL. Long-term survival with ACTH-secreting carcinoma of the pituitary: a case report and review of the literature. J Clin Endocrinol Metab. 2002 Jul;87(7):3084-9. (Pubitemid 34816349)